بدائل البحث:
teer decrease » greater decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), gy decreased (توسيع البحث), b1 decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
5 mean » _ mean (توسيع البحث), a mean (توسيع البحث), i mean (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), gy decreased (توسيع البحث), b1 decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
5 mean » _ mean (توسيع البحث), a mean (توسيع البحث), i mean (توسيع البحث)
-
11941
Defects of neural tube and motoneuron formation in <i>dlx5a/6a</i> zebrafish morphants.
منشور في 2019"…The <i>dlx5a/6a</i> morphants show a reduced neural tube (A’-D’) associated with a defect of NCC migration (B’, black arrowhead), aberrant accumulation of <i>foxd3</i> and <i>ncad</i> transcripts in somites (B, D) and decrease of <i>msx1b</i> in the neural tube (F, black arrowhead). …"
-
11942
-
11943
-
11944
Chest Compression Synchronized Ventilation versus Intermitted Positive Pressure Ventilation during Cardiopulmonary Resuscitation in a Pig Model
منشور في 2015"…Pigs were mechanically ventilated in a cross-over setting with 5 ventilation periods of 4min each: Ventilation modes were during the first and last period IPPV (100% O<sub>2</sub>, tidalvolumes = 7ml/kgKG, respiratoryrate = 10/min), during the 2nd, 3rd and 4th period CCSV (100% O<sub>2</sub>), a pressure-controlled and with each chest compression synchronized breathing pattern with three different presets in randomized order. …"
-
11945
-
11946
-
11947
-
11948
Cumulative release of Mn<sup>2+</sup> from MnO NPs over 24 hr after incubation in PBS pH 7.4 (dotted line), 20 mM citrate buffer pH 6.5 (dashed line), and 20 mM citrate buffer pH 5...
منشور في 2020"…<p>Controlled release curves are shown for MnO NPs generated with the following temperature profiles: a) 5 min at 300°C with 20°C/min ramp, b) 5 min at 300°C with 10°C/min ramp, c) 15 min at 300°C with 20°C/min ramp, d) 15 min at 300°C with 10°C/min ramp, and e) 30 min at 300°C with 10°C/min ramp. …"
-
11949
BMT has long term effects on white adipose tissue.
منشور في 2017"…<p>(A) Weight of sWAT and vWAT pads was decreased in BMT-treated mice as compared to control mice. …"
-
11950
-
11951
-
11952
ACKR2 contributes to pulmonary dysfunction by shaping CCL5:CCR5-dependent recruitment of lymphocytes during Influenza A infection in mice
منشور في 2019"…<p>Supplementary Figure 3 – Proposed mechanism: ACKR2 decreased pulmonary tolerance to influenza A virus infection by reducing CCL5 levels and impairing the development of cellular and humoral antiviral responses and tissue protection. …"
-
11953
-
11954
Somatic cell count (SCC) of control cows and cows supplemented with <i>S</i>. <i>baicalensis</i> extract (SBE) during the first 5 d (SBE5) or 60 d (SBE60) of lactation.
منشور في 2019"…Somatic cell count was not different between SBE5 and control during wk 1–9 (<i>P</i> = 0.37) or wk 10–17 (<i>P</i> = 0.29). …"
-
11955
-
11956
Analyze data.
منشور في 2025"…Compared with the Sham surgery group, there was a significant decrease in NeuN over time (P < 0.01) and a significant increase in IBA-1 and CIRBP (P < 0.01) in the severe injury group. …"
-
11957
Mouse spinal cord injury strike parame.
منشور في 2025"…Compared with the Sham surgery group, there was a significant decrease in NeuN over time (P < 0.01) and a significant increase in IBA-1 and CIRBP (P < 0.01) in the severe injury group. …"
-
11958
-
11959
Image_5_Myricetin, the Main Flavonoid in Syzygium cumini Leaf, Is a Novel Inhibitor of Platelet Thiol Isomerases PDI and ERp5.tif
منشور في 2020"…Additionally, myricetin is a novel inhibitor of ERp5 and PDI, unveiling a new therapeutic perspective for the treatment of thrombotic disorders.…"
-
11960
Image_5_Myricetin, the Main Flavonoid in Syzygium cumini Leaf, Is a Novel Inhibitor of Platelet Thiol Isomerases PDI and ERp5.tif
منشور في 2020"…Additionally, myricetin is a novel inhibitor of ERp5 and PDI, unveiling a new therapeutic perspective for the treatment of thrombotic disorders.…"